Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: A study using CRH-deficient mice

Neuroscience Letters

Volumn 367, Issue 2, 2004, Pages 201-204

  Fukuda, Yoshiko ^a   Kageyama, Kazunori ^a   Nigawara, Takeshi ^a   Kasagi, Yoko ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Endorphin; Adrenocorticotropin; CRH; POMC; Stress

Indexed keywords

BETA ENDORPHIN; BETA LIPOTROPIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FURIN; HORMONE PRECURSOR; PROOPIOMELANOCORTIN;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; GEL FILTRATION CHROMATOGRAPHY; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MOLECULAR MECHANICS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; WILD TYPE;

ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; BETA-ENDORPHIN; BETA-LIPOTROPIN; CHROMATOGRAPHY, GEL; CORTICOTROPIN-RELEASING HORMONE; HYPOPHYSECTOMY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PAIN; PITUITARY GLAND, ANTERIOR; PRO-OPIOMELANOCORTIN; RADIOIMMUNOASSAY;

EID: 4344601604     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.06.006     Document Type: Article

References (14)

1. Benjannet S., Rondeau N., Day R., Chretien M., Seidah N.G. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3564-3568
2. Castro M.G., Gusovsky F., Loh Y.P. Transmembrane signals mediating adrenocorticotropin release from mouse anterior pituitary cells. Mol. Cell. Endocrinol. 65:1989;165-173
3. Mains R.E., Eipper B.A., Ling N. Common precursor to corticotropin and endorphins. Proc. Natl. Acad. Sci. U.S.A. 74:1977;3014-3018
4. Muglia L., Jacobson L., Dikkes P., Majzoub J.A. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature. 373:1995;427-432
5. Muglia L.J., Jacobson L., Luedke C., Vogt S.K., Schaefer M.L., Dikkes P., Fukuda S., Sakai Y., Suda T., Majzoub J.A. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. J. Clin. Invest. 105:2000;1269-1277
6. Muglia L.J., Jacobson L., Weninger S.C., Luedke C.E., Bae D.S., Jeong K.H., Majzoub J.A. Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. J. Clin. Invest. 99:1997;2923-2929
7. Muglia L.J., Jenkins N.A., Gilbert D.J., Copeland N.G., Majzoub J.A. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J. Clin. Invest. 93:1994;2066-2072
8. Suda T., Kondo M., Totani R., Hashimoto N., Suzuki M., Imaki T., Oba Y., Tomori N., Yajima F., Sumitomo T., Nakagami Y., Ushiyama T., Demura H., Shizume K. Ectopic adrenocorticotropin syndrome caused by lung cancer that responded to corticotropin-releasing hormone. J. Clin. Endocrinol. Metab. 63:1986;1047-1051
9. Suda T., Nakano Y., Tozawa F., Sumitomo T., Sato Y., Yamada M., Demura H. The role of corticotropin-releasing factor and vasopressin in hypoglycemia-induced proopiomelanocortin gene expression in the rat anterior pituitary gland. Brain Res. 579:1992;303-308
10. Suda T., Tomori N., Tozawa F., Mouri T., Demura H., Shizume K. Effect of dexamethasone on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary. Endocrinology. 114:1984;851-854
11. Suda T., Tomori N., Tozawa F., Tozawa R., Demura H., Shizume K., Mouri T., Miura Y., Sasano N. Immunoreactive corticotropin and corticotropin-releasing factor in human hypothalamus, adrenal, lung cancer, and pheochromocytoma. J. Clin. Endocrinol. Metab. 58:1984;919-924
12. Suda T., Tozawa F., Yamaguchi H., Shibasaki T., Demura H., Shizume K. Multiple forms of immunoreactive β-endorphin are present in an ectopic adrenocorticotropin-producing tumor but not in normal pituitary or pituitary adenomas. J. Clin. Endocrinol. Metab. 54:1982;167-171
13. Tanoue A., Ito S., Honda K., Oshikawa S., Kitagawa Y., Koshimizu T.-A., Mori T., Tsujimoto G. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J. Clin. Invest. 113:2004;302-309
14. Vale W., Rivier C., Brown M.R., Spiess J., Koob G., Swanson L., Bilezikjian L., Bloom F., Rivier J. Chemical and biological characterization of corticotropin releasing factor. Recent Prog. Horm. Res. 39:1983;245-270